$ODTX SEC Filings

Filed On	Filing
20 Oct 2026	8-K: Regulation FD Disclosure Forward-looking statements and third-party information This presentation contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. All statements other...
09 Sep 2026	8-K: Regulation FD Disclosure Confidential information, forward-looking statements, and third-party information This presentation (including any discussion that accompanies this presentation) contains highly confidential information regarding Odyssey Therapeutics, In...
06 Aug 2026	10-Q
04 Aug 2026	8-K: Results of Operations and Financial Condition
23 Jun 2026	8-K: Regulation FD Disclosure
17 Jun 2026	10-Q
17 Jun 2026	8-K: Results of Operations and Financial Condition
05 Jun 2026	SCHEDULE 13G
18 May 2026	SCHEDULE 13G
18 May 2026	SCHEDULE 13D
18 May 2026	SCHEDULE 13D
15 May 2026	SCHEDULE 13D
15 May 2026	SCHEDULE 13D
13 May 2026	Form 4: Tpg Gp A, Llc, Former 10% Owner and 2 others Acquired 423,111 shares (Other Transaction) · Disposed of 2,351 shares (Other Transaction) ($42.3K) · Received 1,880,497 shares by conversion · 2 more
12 May 2026	Form 4: Dimension Capital II, L.p., Director Received 1,709,543 shares by conversion · Bought 1,111,111 shares ($20M)
12 May 2026	Form 3: Dimension Capital II, L.p., Director Holds 512,862 shares of Common Stock
11 May 2026	Form 4: Sr One Capital MANAGEMENT, Llc, 10% owner and 1 other Received 2,921,061 shares by conversion · Received 320,047 shares by exercise · Sold 1,780 shares ($32K) · 1 more
11 May 2026	Form 4: Leiden Jeffrey M, Director Granted 626,220 Stock Option (Right to Buy) · Bought 5,000 shares ($100K) · Received 28,698 shares by conversion · 2 more
11 May 2026	Form 4: Haas Jason, Chief Financial Officer Bought 1,000 shares ($20K)
11 May 2026	Form 4: Li Nan (LN), Director Received 1,709,543 shares by conversion · Bought 1,111,111 shares ($20M)

Comments